Indapamid Pmcs

Indapamide, the active ingredient in Indapamid Pmcs, is a thiazide‑like diuretic presented as an oral tablet for systemic use. It is employed to manage hypertension and to reduce fluid overload in patients with heart‑failure‑related or renal‑disease‑related edema.

GNH USA supplies Indapamid Pmcs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal tubular system to control blood pressure and fluid balance, making it useful in several cardiovascular and renal conditions.

- Hypertension: lowers systolic and diastolic pressure, helping to prevent stroke and heart attack. - Edema associated with heart failure: promotes diuresis to reduce excess fluid and improve symptoms. - Edema associated with renal disease: enhances urinary sodium and water excretion, alleviating swelling.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased urinary frequency - Fatigue - Nausea or abdominal discomfort - Mild electrolyte disturbances (e.g., low potassium)

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance (hypokalemia, hyponatremia) - Gout attacks due to elevated uric acid - Allergic reactions such as rash or angioedema - Blood dyscrasias (e.g., leukopenia, thrombocytopenia) - Pancreatitis - Acute renal failure in susceptible individuals

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters.

- Renal function: evaluate creatinine clearance and adjust use if impaired. - Electrolytes: check serum potassium and sodium before and during treatment. - Diabetes: monitor blood glucose as diuretics may affect glycemic control. - Gout: be aware of potential uric acid elevation. - Concomitant antihypertensives: watch for additive blood‑pressure lowering effects. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Indapamide can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - NSAIDs: may reduce diuretic efficacy and impair renal function. - ACE inhibitors/ARBs: combined use can precipitate significant hypotension or renal impairment.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: enhanced hypoglycaemic effect, monitor glucose. - Digoxin: risk of digoxin toxicity due to electrolyte shifts. - Corticosteroids: may increase risk of hypokalemia. - Anticoagulants: possible alteration of INR, require monitoring.